Global Animal Blood Plasma Products and Derivatives Market to Reach US$2.5 Billion by 2030
The global market for Animal Blood Plasma Products and Derivatives estimated at US$1.6 Billion in the year 2023, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. Cell Culture Media Application, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$908.8 Million by the end of the analysis period. Growth in the Food Industry Application segment is estimated at 5.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$438.4 Million While China is Forecast to Grow at 6.1% CAGR
The Animal Blood Plasma Products and Derivatives market in the U.S. is estimated at US$438.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$386.6 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.
Global Animal Blood Plasma Products and Derivatives Market - Key Trends & Drivers Summarized
Why Are Animal Blood Plasma Products and Derivatives Increasingly Important in Modern Applications?
Animal blood plasma products and derivatives are gaining significant attention across various industries, driven by their functional and nutritional benefits. These products, derived primarily from livestock like cattle and pigs, are used extensively in sectors such as animal feed, pharmaceuticals, food, and cosmetics. In the animal feed industry, plasma proteins are highly valued for their ability to promote growth and improve the immune response in livestock, making them an essential component of feed for young animals, particularly in weaning piglets. In the food industry, plasma derivatives are utilized as emulsifiers, gelling agents, and water-binding agents, enhancing the texture and nutritional profile of processed foods. As consumer demand for high-quality animal protein products grows, so does the need for these derivatives, which improve both product performance and sustainability in food production.
What Technological Advances Are Shaping the Animal Blood Plasma Market?
Technological innovations are playing a key role in expanding the uses and applications of animal blood plasma products and derivatives. Advancements in fractionation technology, for instance, have made it possible to isolate specific proteins and bioactive compounds from plasma, which can be used in various specialized applications. In the pharmaceutical industry, plasma-derived proteins are increasingly being used in the development of novel therapeutics for immune disorders and wound healing. The emergence of biotechnological processes to enhance the functionality of these proteins has opened new doors in the fields of regenerative medicine and biopharmaceuticals. Furthermore, improvements in the preservation and transportation of plasma products are enhancing their stability and usability across global markets, leading to wider adoption in sectors that require high-quality, bioactive ingredients.
What Are the Regulatory Challenges Facing the Animal Blood Plasma Market?
The animal blood plasma products and derivatives market is highly regulated, particularly in the food and pharmaceutical sectors, where safety and quality are paramount. Regulatory agencies such as the FDA, EFSA, and USDA have strict guidelines governing the collection, processing, and use of animal-derived plasma products to ensure they are safe for both human and animal consumption. One of the key challenges in this market is ensuring traceability and transparency in the supply chain, as well as maintaining high standards of hygiene and biosafety during plasma extraction and processing. As consumers become more conscious of the ethical and health implications of animal-derived products, regulations concerning animal welfare, sustainability, and product labeling are also becoming more stringent. This regulatory framework is pushing manufacturers to adopt better practices in plasma collection and product development, which, while challenging, also fosters innovation in the industry.
What Factors Are Driving the Growth of the Animal Blood Plasma Products and Derivatives Market?
The growth in the animal blood plasma products and derivatives market is driven by several factors, including increasing demand for high-quality animal feed, growing applications in the pharmaceutical and food industries, and advancements in plasma processing technologies. In the animal feed sector, the need to improve livestock health and productivity, especially in young and weaning animals, is fueling demand for plasma proteins. The food industry is seeing increased use of plasma derivatives as functional ingredients that enhance product quality and shelf life. The rising awareness of the nutritional benefits of these derivatives in human health supplements is also expanding their use in the nutraceutical sector. Furthermore, the pharmaceutical industry`s focus on developing biologically active ingredients for immune modulation and tissue repair is opening new avenues for the application of plasma-derived products, contributing to the market`s robust growth trajectory.
Select Competitors (Total 44 Featured) -Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook